D. E. Shaw & Co., Inc. - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 206 filers reported holding MYRIAD GENETICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$34,933,917
-25.7%
2,177,925
+7.4%
0.04%
-25.0%
Q2 2023$46,986,370
+2.0%
2,027,022
+2.3%
0.05%
-2.0%
Q1 2023$46,049,410
+70.9%
1,982,325
+6.7%
0.05%
+63.3%
Q4 2022$26,949,423
-19.6%
1,857,300
+5.7%
0.03%
-25.0%
Q3 2022$33,513,000
-9.6%
1,756,466
-13.9%
0.04%
-7.0%
Q2 2022$37,082,000
-22.0%
2,040,860
+8.2%
0.04%
-4.4%
Q1 2022$47,542,000
-9.7%
1,886,574
-1.1%
0.04%
+2.3%
Q4 2021$52,650,000
-18.8%
1,907,604
-5.0%
0.04%
-25.4%
Q3 2021$64,866,000
-5.4%
2,008,862
-10.4%
0.06%0.0%
Q2 2021$68,581,000
-15.3%
2,242,669
-15.7%
0.06%
-24.4%
Q1 2021$80,988,000
+27.4%
2,659,707
-17.3%
0.08%
+36.8%
Q4 2020$63,585,000
+42.9%
3,215,449
-5.8%
0.06%
+23.9%
Q3 2020$44,510,000
+19.3%
3,413,413
+3.8%
0.05%
+4.5%
Q2 2020$37,301,000
-2.7%
3,289,330
+22.7%
0.04%
-26.7%
Q1 2020$38,353,000
-50.9%
2,680,158
-6.6%
0.06%
-32.6%
Q4 2019$78,107,000
+9.0%
2,868,414
+14.6%
0.09%
+1.1%
Q3 2019$71,683,000
-22.3%
2,503,769
-24.7%
0.09%
-23.5%
Q2 2019$92,315,000
-27.7%
3,323,096
-13.6%
0.12%
-30.3%
Q1 2019$127,702,000
+12.0%
3,846,442
-1.9%
0.16%
+5.1%
Q4 2018$114,037,000
-36.3%
3,922,852
+0.8%
0.16%
-27.0%
Q3 2018$179,077,000
+18.3%
3,892,978
-3.9%
0.22%
+9.1%
Q2 2018$151,376,000
+22.5%
4,050,733
-3.2%
0.20%
+17.3%
Q1 2018$123,620,000
-24.4%
4,183,415
-12.2%
0.17%
-25.3%
Q4 2017$163,616,000
-7.1%
4,763,889
-2.1%
0.22%
-16.7%
Q3 2017$176,048,000
+41.0%
4,865,903
+0.7%
0.27%
+31.1%
Q2 2017$124,861,000
+53.0%
4,832,111
+13.7%
0.21%
+43.1%
Q1 2017$81,602,000
+76.7%
4,250,049
+53.4%
0.14%
+84.6%
Q4 2016$46,178,000
+0.9%
2,770,122
+24.6%
0.08%
-3.7%
Q3 2016$45,755,000
-48.5%
2,223,285
-23.5%
0.08%
-50.6%
Q2 2016$88,877,000
-18.9%
2,904,477
-0.8%
0.16%
-16.8%
Q1 2016$109,601,000
+2.4%
2,928,144
+18.1%
0.20%
+23.9%
Q4 2015$107,000,000
+37.4%
2,479,159
+19.3%
0.16%
+38.3%
Q3 2015$77,855,000
+44.0%
2,077,242
+30.6%
0.12%
+42.0%
Q2 2015$54,076,000
+5.2%
1,590,935
+9.5%
0.08%
+2.5%
Q1 2015$51,419,000
-0.8%
1,452,509
-4.6%
0.08%
+17.9%
Q4 2014$51,844,000
-10.9%
1,522,159
+0.9%
0.07%
-10.7%
Q3 2014$58,175,000
+87.3%
1,508,303
+89.0%
0.08%
+78.6%
Q2 2014$31,055,000
+1074.1%
797,907
+931.3%
0.04%
+950.0%
Q1 2014$2,645,000
-60.8%
77,367
-75.9%
0.00%
-55.6%
Q4 2013$6,749,000
+21.3%
321,680
+35.9%
0.01%0.0%
Q3 2013$5,562,000
-82.5%
236,702
-80.0%
0.01%
-85.0%
Q2 2013$31,844,0001,185,1010.06%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders